A proposed framework to evaluate the quality and reliability of targeted metabolomics assays from the UK Consortium on Metabolic Phenotyping (MAP/UK)

Sarmad, Sarir; Viant, Mark R.; Dunn, Warwick B.; Goodacre, Royston; Wilson, Ian D.; Chappell, Katie E.; Griffin, Julian L.; O’Donnell, Valerie B.; Naicker, Brendon; Lewis, Matthew R.; Suzuki, Toru; UK Consortium on Metabolic Phenotyping (MAP/UK)

doi:10.1038/s41596-022-00801-8

All Outputs (2)

Differential implications of gut-related metabolites on outcomes between heart failure and myocardial infarction (2023)
Journal Article
Israr, M. Z., Salzano, A., Sarmad, S., Ng, L. L., & Suzuki, T. (2024). Differential implications of gut-related metabolites on outcomes between heart failure and myocardial infarction. European Journal of Preventive Cardiology, 31(3), 368-372. https://doi.org/10.1093/eurjpc/zwad305

A proposed framework to evaluate the quality and reliability of targeted metabolomics assays from the UK Consortium on Metabolic Phenotyping (MAP/UK) (2023)
Journal Article
Sarmad, S., Viant, M. R., Dunn, W. B., Goodacre, R., Wilson, I. D., Chappell, K. E., Griffin, J. L., O’Donnell, V. B., Naicker, B., Lewis, M. R., Suzuki, T., & UK Consortium on Metabolic Phenotyping (MAP/UK). (2023). A proposed framework to evaluate the quality and reliability of targeted metabolomics assays from the UK Consortium on Metabolic Phenotyping (MAP/UK). Nature Protocols, 18(4), 1017-1027. https://doi.org/10.1038/s41596-022-00801-8

Targeted metabolite assays that measure tens or hundreds of pre-selected metabolites, typically using liquid chromatography–mass spectrometry, are increasingly being developed and applied to metabolic phenotyping studies. These are used both as stand... Read More about A proposed framework to evaluate the quality and reliability of targeted metabolomics assays from the UK Consortium on Metabolic Phenotyping (MAP/UK).